Gene · 5908
Papers1,432
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,432
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of RAPGEF3 as the therapeutic vulnerability of basal-subtype lung squamous cell carcinoma. | Oncogene | 2025 | 40781157 | PubTator, text mining | PubMed |
| Retraction: Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells via the PI3K/Akt/mTOR Pathway. | Oncol Res | 2025 | 40746886 | PubTator, text mining | PubMed |
| Transcriptome profiling reveals major structural genes, transcription factors and biosynthetic pathways in refractory epilepsy in tropical region of China. | BMC Neurol | 2025 | 40646440 | PubTator, text mining | PubMed |
| Fibronectin 1 Aggravates Colon Cancer Metastasis by Regulating RAP1B Protein Stability Through Akt/CREB Signalling Pathway. | J Cell Mol Med | 2025 | 40638546 | PubTator, text mining | PubMed |
| Computational model predicts function of Rho-GTPase binding for plexin receptor GAP activity on Rap1b via dynamic allosteric changes. | Protein Sci | 2025 | 40545673 | PubTator, text mining | PubMed |
| Divergent Functions of Rap1A and Rap1B in Endothelial Biology and Disease. | Int J Mol Sci | 2025 | 40508181 | PubTator, text mining | PubMed |
| COMMD10 Regulates Angiogenesis and Bone Formation via Rap1 Signaling Pathway. | FASEB Bioadv | 2025 | 40496352 | PubTator, text mining | PubMed |
| Computation model predicts Rho GTPase function with the Plexin Transmembrane receptor GAP activity on Rap1b via dynamic allosteric changes. | bioRxiv | 2025 | 40462934 | PubTator, text mining | PubMed |
| Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples. | BMC Cancer | 2025 | 40375170 | PubTator, text mining | PubMed |
| Overexpression of FMOD in Thyroid Carcinoma Triggers M1-Like Tumor-Associated Macrophage Polarization by Targeting Rap1B. | FASEB J | 2025 | 40297936 | PubTator, text mining | PubMed |
| Dapagliflozin activates the RAP1B/NRF2/GPX4 signaling and promotes mitochondrial biogenesis to alleviate vascular endothelial ferroptosis. | Cell Signal | 2025 | 40280228 | PubTator, text mining | PubMed |
| miR-28-5p targeted Rap1b attenuates splenic inflammation infiltration in immune thrombocytopenia. | Platelets | 2025 | 40197264 | PubTator, text mining | PubMed |
| The Significance of MAPK Signaling Pathway in the Diagnosis and Subtype Classification of Intervertebral Disc Degeneration. | JOR Spine | 2025 | 40134951 | PubTator, text mining | PubMed |
| Hepatocyte-specific RAP1B deficiency ameliorates high-fat diet-induced obesity and liver inflammation in mice. | Diabetes Obes Metab | 2025 | 40083059 | PubTator, text mining | PubMed |
| The small GTPase Rap1 in POMC neurons regulates leptin actions and glucose metabolism. | Mol Metab | 2025 | 40024570 | PubTator, text mining | PubMed |
| Rap1 Guanosine Triphosphate Hydrolase (GTPase) Regulates Shear Stress-Mediated Adhesion of Mesenchymal Stromal Cells. | Biology (Basel) | 2025 | 39857326 | PubTator, text mining | PubMed |
| Platelet inhibition by hypochlorous acid involves cAMP signalling. | Cell Signal | 2025 | 39689749 | PubTator, text mining | PubMed |
| Single-Cell Omics for Transcriptome CHaracterization (SCOTCH): isoform-level characterization of gene expression through long-read single-cell RNA sequencing. | bioRxiv | 2025 | 38746128 | PubTator, text mining | PubMed |
| Epigenome-Wide and Methylation Risk Score Analysis of Body Mass Index Among People with HIV. | Epigenomes | 2024 | 39727808 | PubTator, text mining | PubMed |
| Rap1b: A cytoskeletal regulator Advantageous to viral infection. | iScience | 2024 | 39474066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5908/papers?page=3